Related Experiment Video
Updated: Oct 29, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Ceftaroline-related acute eosinophilic pneumonia
Zaw Min1, Rawiya Elrufay1, Christian Y Cho2
1Division of Infectious Disease, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Ceftaroline fosamil, an antibiotic effective against MRSA, can rarely cause acute eosinophilic pneumonia. Early recognition and steroid treatment are crucial for recovery from this adverse drug reaction.
Area of Science:
- Infectious Diseases
- Pulmonology
- Pharmacology
Background:
- Ceftaroline fosamil is a 5th-generation cephalosporin effective against Gram-positive and Gram-negative bacteria, including MRSA.
- Approved for skin infections and pneumonia, its adverse effects are generally mild, but rare complications can occur.
More Related Videos
03:23Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Pyelonephritis I: Introduction
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: